Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-7phn8yvPhase 4Not yet recruiting
Phase 4, randomised, double-blind trial of ketorolac, Metamizole sodium, hyoscine butylbromide and homatropine methylbromide (2 arms), sponsored by Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM. Planned start Nov 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-7phn8yv.